TN
Transgene
TNG.PA·EPAStrasbourg FRFounded 1979250 employees
Micro CapbiotechPublicOncology
Platform: TG4050 MVA
Market Cap
$0.15B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (TNG.PA)
Loading TNG.PA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sovaratamab | TNG-8571 | Phase 2/3 | 2 | FLT3 | CeliacCKD | ||
| TNG-3308 | TNG-3308 | Preclinical | 1 | CDK4/6 | ACCCeliac |
SEC Filings & Financial Documents
SEC filings are not available for EPA-listed companies.
Transgene trades on EPA (FR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)